Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
The WTO IP waiver for COVID-19 vaccines was never about vaccine distribution—it was a political calculation, according to Hans Sauer, Deputy General Counsel for […]
WTO IP waiver was always political: BIO’s patent lawyer breaks it down Read More »
The Inflation Reduction Act (IRA), signed into law on August 16, offered historic investments in energy security and climate change. However, the legislation also
AZBio President: IRA could have ‘long-term, unintended consequences’ Read More »
Rachel King was enjoying her retirement. When the COVID-19 pandemic hit, King found herself with a chance to refocus and ask herself what was
Meet Rachel King, BIO’s new interim CEO and a champion of the biotech industry Read More »
What did we learn on Day 1 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit in Washington, D.C.? It’s all about
What we learned on Day 1 of the Patient and Health Advocacy Summit Read More »
Every member of the Council of State Bioscience Associations (CSBA) signed a letter to President Biden expressing serious concerns with the proposed expansion of a
Expanding WTO IP waiver would hurt SMEs, CSBA tells Biden Read More »
The Biotechnology Innovation Organization (BIO) kicked off Day One of its two-day Patient and Health Advocacy Summit with a welcome from Eric Dube, President
The Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit returns to an in-person format for the first time since before the COVID-19 pandemic—and
What to know about the BIO Patient and Health Advocacy Summit Read More »
The Biotechnology Innovation Organization (BIO), the world’s largest science and public advocacy organization for biotech companies, announced a leadership update and the appointment of
BIO announces leadership changes, interim CEO Read More »
After two years of virtual programming, the Congressional Black Caucus Foundation’s Annual Legislative Conference (ALC) was held in person from September 28 through October
BIO addresses clinical trial diversity at CBC Annual Legislative Conference event Read More »
After making the misguided decision to waive intellectual property (IP) protections for COVID vaccines, the World Trade Organization (WTO) is thinking about extending the
BIO: Expanding COVID IP waiver could harm US biotech companies Read More »
